Clinical trial
Current Status of Diagnosis, Treatment and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis
NCT06629623 is registered in ClinicalTrials.gov with Chu Hongling as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Current Status of Diagnosis, Treatment and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis
- Lead sponsor
- Chu Hongling
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- July 30, 2024
- Completion date
- December 30, 2025
- Enrollment
- 310 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.